SMALL CAP PORTFOLIO Let's be extra careful out there today! SUMMARY There is something rotten in the state of Denmark! Why CSL and RMD are on the nose. Is GLP-1 bigger than AI? The MGFO punt is paying off nicely. Forager showing a way forward. US CPI. More normal rates for longer. Sticky Fingers. Thoughts…
Turnover day – Not sure you take much interest in the technical signals today as the four-day trend comes to an end. Not a lot of technical signals anyway as the market bounce drops away. This is the ASX 200 – will the new trend end? Likely.
All Change – We are back on interest rate watch after the CPI number. Interest rate sensitive rally to end. US Results season starts tonight. Usually, a positive. Investment banks up first. DMP – Some broker upgrades. SGR – If you can swallow your ethics. BOQ after dropping 7% on results. Interesting moves in our industry.
ASX 200 performs better than expected, falling only 40 points to 7051 (-0.6%). Volumes seemed light, and some book squaring ahead of US results helped sentiment. Banks eased back, with CBA down 0.6% and the Big Bank Basket down to $177.48 (-0.7%). Insurers slightly better IAG up 0.2%. Fund managers eased back, and REITs fell back as 10-year yields…
ASX 200 limped to a 3-point gain to 7091 (+0.04%) ahead of US CPI. Six sessions in a row. Just. CSL was the biggest drag on the index as positive drug trials in the US marred the outlook for medical companies. The stock fell 6.3%, RMD down 5.3% on the same effect. Banks once again…
US equities finished higher overnight after a choppy session following the release of FOMC meeting minutes, which showed caution among policymakers, fuelling bets that rates would stay steady. The Dow edged higher, up 66 points (+0.19%). Up 143 at best. Down 127 at worst. The S&P 500 rose for a fourth straight session, up 0.43%,…
SMALL CAP PORTFOLIO 3.00pm Updates Nothing done today. Selected lithium stocks recovering from oversold levels. PMT, CXO, AZS to name a few. Market impetus running out as US CPI approaches. Volumes in small caps remain low. CSL a major drag as US Med tech under pressure on new kidney trial results using the ‘miracle’ weight…
Buy signals on the All Ordinaries, ASX 200, S&P 500 and Nasdaq are now 4 days old. There are now MACD buy signals as well. Telstra (TLS) weekly buy signal. Again. Not often traded by Australians – but there’s a buy signal on SQ2. Qantas (QAN), anyone?. Very early short-term buy signal after dropping from 670c to 490c over the Qatar debacle (not their fault).
The Doves are still flapping – we are four days into this market rally
